去年，美敦力表现最佳的业务板块Cardiac Rhythm & Heart Failure实现营收7.50B美元。Rest of World的营收贡献最高，去年达到18.12B美元。最近一个季度，截至2026-04-24，美敦力表现最佳的业务板块Cardiac Rhythm & Heart Failure实现营收2.11B美元。Rest of World的营收贡献最高，达到4.90B美元。

业务

营业收入

占比

年报

年报

单季报

Cardiac Rhythm & Heart Failure

Surgical & Endoscopy

Cranial & Spinal Technologies

Coronary & Peripheral Vascular

Specialty Therapies

Structural Heart & Aortic

Neuromodulation

Patient Monitoring & Respiratory Interventions

Other

Other adjustments

Coronary & Peripheral Vascular

Brain Therapies

Spine

Pain Therapies

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Cardiac Rhythm & Heart Failure

7.50B(22.57%)

6.39B(20.77%)

6.00B(20.07%)

5.78B(19.31%)

5.85B(19.94%)

5.58B(20.16%)

5.14B(19.37%)

5.85B(20.77%)

Surgical & Endoscopy

6.76B(20.34%)

6.50B(21.11%)

6.51B(21.78%)

6.15B(20.54%)

6.54B(22.30%)

5.44B(19.63%)

5.51B(20.77%)

5.75B(20.43%)

Cranial & Spinal Technologies

5.22B(15.70%)

4.97B(16.16%)

4.76B(15.92%)

4.45B(14.86%)

4.46B(15.18%)

4.29B(15.48%)

--(--)

Coronary & Peripheral Vascular

3.82B(11.48%)

--(--)

Specialty Therapies

3.00B(9.01%)

2.94B(9.55%)

2.90B(9.72%)

2.81B(9.40%)

2.59B(8.83%)

2.31B(8.33%)

1.19B(4.49%)

1.64B(5.83%)

Structural Heart & Aortic

2.66B(7.99%)

3.55B(11.55%)

3.36B(11.24%)

3.36B(11.23%)

3.06B(10.41%)

2.35B(8.50%)

1.79B(6.73%)

1.93B(6.84%)

Neuromodulation

2.07B(6.22%)

1.93B(6.28%)

1.75B(5.84%)

1.69B(5.65%)

1.74B(5.91%)

1.60B(5.78%)

--(--)

Patient Monitoring & Respiratory Interventions

2.05B(6.17%)

1.91B(6.20%)

1.91B(6.39%)

1.84B(6.13%)

1.93B(6.56%)

3.30B(11.90%)

2.84B(10.70%)

2.73B(9.67%)

Other

135.00M(0.41%)

137.00M(0.45%)

221.00M(0.74%)

495.00M(1.65%)

727.00M(2.48%)

--(--)

Other adjustments

39.00M(0.12%)

-90.00M(-0.29%)

--(--)

Coronary & Peripheral Vascular

--(--)

2.54B(8.24%)

2.48B(8.29%)

3.36B(11.23%)

2.46B(8.38%)

2.83B(10.23%)

3.54B(13.34%)

3.73B(13.24%)

Brain Therapies

--(--)

2.92B(11.01%)

2.60B(9.25%)

Spine

--(--)

2.50B(9.43%)

2.65B(9.42%)

Pain Therapies

--(--)

1.11B(4.17%)

1.28B(4.56%)

地区

营业收入

占比

年报

年报

单季报

Rest of World

United States

Ireland

Americas

EMEA

Asia Pacific

Other Foreign

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

Rest of World

18.12B(49.82%)

16.25B(48.45%)

15.69B(48.48%)

14.76B(47.25%)

15.45B(48.76%)

14.49B(48.12%)

13.91B(48.11%)

14.27B(46.71%)

13.99B(46.72%)

12.98B(43.68%)

12.33B(42.77%)

--(--)

United States

18.10B(49.78%)

17.17B(51.20%)

16.56B(51.17%)

16.37B(52.43%)

16.14B(50.92%)

15.53B(51.55%)

14.92B(51.60%)

16.19B(53.00%)

15.88B(53.00%)

16.66B(56.09%)

16.42B(56.96%)

--(--)

Ireland

143.00M(0.39%)

116.00M(0.35%)

113.00M(0.35%)

98.00M(0.31%)

101.00M(0.32%)

100.00M(0.33%)

85.00M(0.29%)

91.00M(0.30%)

85.00M(0.28%)

69.00M(0.23%)

79.00M(0.27%)

--(--)

Americas

--(--)

12.13B(59.84%)

9.92B(58.35%)

9.76B(58.84%)

8.83B(54.55%)

EMEA

--(--)

5.06B(24.99%)

4.48B(26.36%)

4.22B(25.47%)

4.31B(26.65%)

Asia Pacific

--(--)

2.06B(10.16%)

1.78B(10.44%)

1.89B(11.37%)

2.40B(14.82%)

Other Foreign

--(--)

1.01B(5.00%)

824.00M(4.85%)

718.00M(4.33%)

644.00M(3.98%)